⚖
Compare Funds
See how two funds stack up side by side, real returns, risk, cost and portfolio overlap.
VS
Key Metrics Comparison
| Metric | Bandhan Innovation Fund - Regular Plan - IDCW Reinvest | HDFC Pharma and Healthcare Fund - Growth - Direct Plan |
|---|---|---|
| Snapshot | ||
| AMC | IDFC MF | HDFC MF |
| Category | Equity - Thematic Fund - Other | Equity - Sectoral Fund - Pharma & Health Care |
| NAV | ₹13.91 (30 Oct 2026) | ₹21.95 (30 Oct 2026) |
| Rating | ★★★ | ★★★★★ |
| Benchmark | NIFTY 500 - TRI | BSE Health Care - TRI |
| Fund Manager | Manish Gunwani | Nikhil Mathur |
| Inception | 30 Apr 2024 | 04 Oct 2023 |
| Returns | ||
| 1Y | 9.13% | 22.64% |
| 3Y | — | 30.41% |
| 5Y | — | — |
| Since Inception | 17.42% | 29.15% |
| Risk | ||
| 17.45 | 14.07 | |
| 1.13 | 0.59 | |
| 0.78 | 1.59 | |
| 15.10 | 21.67 | |
| 1.44 | 3.48 | |
| -12.60% | -9.23% | |
| Costs | ||
| Expense Ratio | 2.25% | 1.03% |
| Exit Load | 0.50% on or before 30D, Nil after 30D | 1% on or before 30D, Nil after 30D |
| Min SIP | ₹100 | ₹100 |
| Min Lumpsum | ₹1,000 | ₹100 |
| Lock-in | None | None |
Min SIP is reported per fund, not per plan, every plan of a fund shares the same figure.
Portfolio Overlap
IDFC MF98%
HDFC MF98%
1.7%Only 1.7% of holdings by weight are common between IDFC MF and HDFC MF, based on each fund's top 20 disclosed holdings, not the full portfolio.
Common holdingIDFC MFHDFC MF
Divi's Laboratories Ltd.1.69%9.39%
Category context: Equity vs Equity. Open the full Screener →